PMC:7293470 / 4047-4366
Annnotations
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T130 | 80-83 | GO:0042611 | denotes | MHC |
T131 | 88-97 | CHEBI:59132;CHEBI:59132 | denotes | antigenic |
T132 | 139-142 | GO:0042611 | denotes | MHC |
T133 | 154-161 | CHEBI:59132;CHEBI:59132 | denotes | antigen |
T134 | 171-178 | CL:0000084 | denotes | T cells |
T135 | 184-195 | GO:0006412 | denotes | translation |
T136 | 211-216 | SP_6;NCBITaxon:9606 | denotes | human |
T137 | 292-295 | GO:0042611 | denotes | MHC |
T28841 | 80-83 | GO:0042611 | denotes | MHC |
T93931 | 88-97 | CHEBI:59132;CHEBI:59132 | denotes | antigenic |
T69769 | 139-142 | GO:0042611 | denotes | MHC |
T81989 | 154-161 | CHEBI:59132;CHEBI:59132 | denotes | antigen |
T41673 | 171-178 | CL:0000084 | denotes | T cells |
T85672 | 184-195 | GO:0006412 | denotes | translation |
T81660 | 211-216 | SP_6;NCBITaxon:9606 | denotes | human |
T64396 | 292-295 | GO:0042611 | denotes | MHC |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T53 | 80-83 | Body_part | denotes | MHC | http://purl.org/sig/ont/fma/fma84079 |
T54 | 139-142 | Body_part | denotes | MHC | http://purl.org/sig/ont/fma/fma84079 |
T55 | 173-178 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T56 | 292-295 | Body_part | denotes | MHC | http://purl.org/sig/ont/fma/fma84079 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T65 | 98-105 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptide |
T66 | 171-178 | http://purl.obolibrary.org/obo/CL_0000084 | denotes | T cells |
T67 | 211-216 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T68 | 224-225 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T72 | 15-23 | Chemical | denotes | agonists | http://purl.obolibrary.org/obo/CHEBI_48705 |
T73 | 98-105 | Chemical | denotes | peptide | http://purl.obolibrary.org/obo/CHEBI_16670 |
T74 | 154-161 | Chemical | denotes | antigen | http://purl.obolibrary.org/obo/CHEBI_59132 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T14 | 184-195 | http://purl.obolibrary.org/obo/GO_0006412 | denotes | translation |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T20 | 0-319 | Sentence | denotes | As partial TCR agonists these constructs, containing various disease-associated MHC and antigenic peptide components, could indeed inhibit MHC-restricted antigen specific T cells, but translation of RTL1000 for human use in a Phase 1 clinical trial (showing safety and tolerability) required MHC-matched recipients [7]. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
196 | 80-83 | Gene | denotes | MHC | Gene:3107 |
197 | 292-295 | Gene | denotes | MHC | Gene:3107 |
208 | 211-216 | Species | denotes | human | Tax:9606 |
213 | 139-142 | Gene | denotes | MHC | Gene:3107 |